IGMPI India

Beximco Pharmaceuticals is a generic manufacturer of pharmaceutical products and Active Pharmaceuticals in Bangladesh. It is the first Bangladeshi company to receive GMP (Good Manufacturing Practices) approval from the Canadian regulatory authority, Health Canada. This has opened new marketing opportunity for Beximco Pharma's products in the Canadian market.

Access to generic drugs is being increasingly promoted by Health Canada giving more opportunities to generic drug companies to market their products.As per the managing director of the company Beximco Pharma "Canada is an important market for generic drug products and hence approval by heath Canada marks a significant milestone for the company further raising the quality and compliance standards of the company.This approval has built on the existing presence of Beximco Pharma in the key regulated markets and paves an important way towards making it a global generic drug player.

Earlier in the month of July Beximco Pharma had received GMP approval from Taiwan Food and Drug Authority (TFDA) which is amongst one of the most stringent regulatory agencies and again Beximco Pharma was the first Bangladeshi company to receive it.

Beximco Pharma is already certified by EU regulatory authority and exporting medicines since 2013 and has received approvals from the relevant authorities in Australia, Latin America, Gulf Nations, and South Africa, among others